HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fibrinogen Saint-Germain I: a case of the heterozygous Aalpha GLY 12 --> VAL fibrinogen variant.

Abstract
A fibrinogen variant was suspected based on the results of routine coagulation tests in a 2-year-old asymptomatic child. Coagulation studies showed marked prolongation of both the thrombin and reptilase times, and discrepancy was noted between the level of plasma fibrinogen as measured by a kinetic versus immunological determination. Family studies revealed that the father beared the same abnormality. Studies of purified fibrinogen revealed an impaired release of both fibrinopeptides by thrombin. Fibrin monomer polymerization and fibrin stabilization were normal. DNA sequencing revealed a heterozygous G --> T point mutation in exon 2 of the gene coding for the Aalpha chain, which substituted a Gly for Val at position 12. Although the mutation is the same as in fibrinogen Rouen, fibrinogen Saint-Germain I shows a different fibrinopeptide release pattern and a mild factor V deficiency.
AuthorsF Mathonnet, J Y Peltier, H Detruit, E de Raucourt, J C Alvarez, G M Mazmanian, P de Mazancourt
JournalBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (Blood Coagul Fibrinolysis) Vol. 13 Issue 2 Pg. 149-53 (Mar 2002) ISSN: 0957-5235 [Print] England
PMID11914657 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibrinogens, Abnormal
  • fibrinogen Saint-Germain I
  • Fibrinopeptide A
  • Fibrinopeptide B
Topics
  • Amino Acid Substitution
  • Child, Preschool
  • Coagulation Protein Disorders (diagnosis, genetics)
  • DNA Mutational Analysis
  • Diagnosis, Differential
  • Factor V Deficiency
  • Family Health
  • Female
  • Fibrinogens, Abnormal (genetics)
  • Fibrinopeptide A (analysis)
  • Fibrinopeptide B (analysis)
  • Genetic Variation
  • Heterozygote
  • Humans
  • Point Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: